Jeremy Bender Day One Biopharmaceuticals, Inc. (DAWN) insider trading activity
Jeremy Bender is CHIEF EXECUTIVE OFFICER of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 654,728 shares of DAWN, which is worth approximately $10.6 Million. The most recent transaction as insider was on May 16, 2024, when has been sold 7,873 shares (Common Stock) at a price of $16.08 per share, resulting in proceeds of $126,597. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
655K
9.29%
3M change
44.49%
12M change
Total Value Held
$10.6 Million
Jeremy Bender Transaction History
Also insider at
JB
Jeremy Bender
CHIEF EXECUTIVE OFFICER
South San Francisco, CA